We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nucleic Acid Testing Shown to Increase HIV Detection Yield

By LabMedica International staff writers
Posted on 12 Jul 2010
Community-based HIV testing programs typically use only HIV antibody testing, but nucleic acid testing (NAT) can detect the presence of HIV earlier. More...


Researchers evaluated more than 3,000 patients who sought HIV testing in community-based clinics in or near San Diego (CA, USA) to study the yield of testing with a rapid test plus NAT and to see whether patients would be willing to access their results by phone or computer.

The investigators, from University of California, San Diego (UCSD) School of Medicine (USA), published their study June 14, 2010, in the journal Annals of Internal Medicine, revealed that NAT testing increased the HIV detection yield by 23%, and that a large majority of study participants received their negative test results by automated phone or internet systems.

"While the findings may not be generalized to all populations and testing programs, we did find that NAT programs that include automated systems for result reporting can increase case yield, especially in settings that cater to those men having sex with men," said the study's first author Sheldon Morris, M.D., MPH, assistant clinical professor at UCSD's Antiviral Research Center.

In spite of decades of prevention efforts in the United States, the incidence rate of HIV has remained constant. Because the earliest stages of HIV infection represent a period of maximum infectiousness, early and accurate detection is crucial to control the HIV epidemic. "Extending the use of NAT to routine HIV testing programs might help decrease the HIV incidence rate by identifying persons with acute infection that would otherwise be missed through routine screening,” said Dr. Morris. "In addition, automated reporting of negative results may prove an acceptable and less resource intense alternative to face-to-face reporting.”

The patients were first tested for HIV with a rapid saliva test. If the result was positive, a counselor informed the patient and blood was obtained for a conventional HIV test. If the result was negative, blood was obtained for a NAT. Nearly one quarter of persons with identified cases of HIV had positive results only by NAT testing. More than two-thirds of patients with negative NAT results retrieved them via computer or voicemail.

Most participants in the San Diego study (56%) and those with HIV (91%) were men having sex with men. According to the UCSD researchers, those with higher incomes, younger ages, no testing at substance abuse rehabilitation centers, no recent syphilis, and no methamphetamine use were more likely to access negative NAT results by either internet or voicemail systems.

Related Links:
University of California, San Diego School of Medicine



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.